As previously mentioned, primary cutaneous ALCL belongs to the group of CD30+ T-cell lymphoproliferative disorders, and the distinction between other subtypes within this group requires the integration of clinical, histological, and immunohistochemical findings, and occasionally the results from genetic and/or molecular alterations. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.